First in Europe: CE-marked AI-ECG for two heart diseases

From any ECG to earlier cardiac care

Willem, Idoven’s AI, helps uncover hidden heart disease in the recordings clinicians already have

Trusted by global leaders in life sciences and medtech

AstraZeneca
Abbott
GE Healthcare
Medtronic

AI-ECG analysis, adapted to the way each partner works

Physician reviewing a patient's results

Hospitals and clinicians

From primary care to cardiology

  • Support for routine ECG reads where cardiology isn’t on site
  • Faster review of resting ECGs and long-term recordings (Holter, patches, ICMs), so the most relevant cases are reviewed first
  • Earlier, better-targeted referrals for Heart Failure and ATTR-CM
29 cardiac patterns
Heart failure
ATTR-CM

Technology partners

ECG devices, platforms and AI

  • Embedded in ECG devices (carts, Holters, patches, monitors), so every recording gets AI-ECG analysis
  • Available through clinical AI platforms, deployed within existing hospital workflows
  • Ready to power AI assistants, bringing CE-marked ECG analysis (EU-MDR)
29 cardiac patterns
Heart failure
ATTR-CM

Pharma and clinical trials

From patient finding to clinical trials

  • Identify potentially eligible patients in existing ECG databases
  • Reach under-diagnosed populations, such as ATTR-CM and heart failure
  • Standardized, centralized ECG analysis across sites, countries and devices
29 cardiac patterns
Heart failure
ATTR-CM

What makes Idoven’s platform so powerful

Database

Our AI models are trained on one of the most diverse and longest ECG databases, from both healthy individuals and diagnosed patients.
1.8 million

ECG hours in database, manually annotated for the sole purpose of AI training

hours in database
28,500+

Subjects enrolled in clinical trials

Patients monitored
17

Collaborators from leading EU and US research centres and industry partners on stroke and atrial fibrillation (MAESTRIA H2020)

AI technology, based on science

We have developed diagnostic and prediction machine learning models based on a deep knowledge and basic research of the human heart.
35+

Publications in top-tier scientific journals

2

disease models: Europe’s first AI-ECG CE-marked under EU-MDR for heart failure and cardiac amyloidosis

29

Cardiac patterns detected automatically with AI

 patterns detected automatically

Willem, our AI-ECG analysis platform, certified as Medical Device Class IIa

Willem 2.0 is certified under Regulation (EU) 2017/745 on Medical Devices (Class IIa), for use by qualified healthcare professionals. From a standard 12-lead resting ECG, it helps identify patients suggestive of heart failure and ATTR cardiac amyloidosis. It also detects 29 arrhythmias and 4 intervals (P interval, PR interval, QT interval and QRS duration) across different ECG recording device types:
Ambulatory ECG
Holter and patch monitors (1–2 lead)
Resting ECG Standard 12-lead devices
Insertable cardiac monitors (ICM)

CE marked - Class IIa
(EU MDR)

Security & data privacy

Our cloud-based infrastructure provides reliability, compliance and security.

Device neutrality & interoperability

Our solution is device neutral and made available to customer via API and non-API tools to enable bi-directional data exchange.
EDF, HL7, DICOM, JSON, XML, PDF...

Ingests data from standard and proprietary formats.

30 seconds to 30 days

Analyses ECGs of any duration, to deliver results in minutes.

ECGs, holters, patches, implantables, wearables
ECGs, holters, patches, implantables, wearables...

Works with any ECG device compliant with standards IEC 60601-2-25, IEC 60601-2-27 and IEC 60601-2-47

Download the Clinical Evidence Behind Our Technology

Get our Clinical Evidence
Iker Casillas, Idoven investor & ambassador

The first app where your heartbeats can save lives

Sync your Apple Watch and share your ECGs anonymously

Contribute to groundbreaking cardiology research

Join a global movement in the fight against heart disease

Our Global Network of Clinical Partners

Since the beginning, Idoven has collaborated with clinical partners in more than 20 countries across Europe and beyond, working on clinical studies, research consortia, and real-world deployments to develop and clinically validate AI for cardiology.

November 17, 2026

Willem 2.0: a routine ECG can now help detect two heart diseases that take years to diagnose

September 29, 2025

Donate Your Heartbeats App: turning everyday signals into life-saving knowledge

September 17, 2025

Idoven featured on the cover of Forward: Unlocking Europe’s AI Potential

1 Willem interpretation results are not intended to be the sole means of diagnosis. It is offered to physicians and clinicians on an advisory basis only in conjunction with the physician’s knowledge of ECG patterns, patient background, clinical history, symptoms, and other diagnostic information.

Download our Clinical Evidence

Contact

Revolutionize cardiovascular care with Idoven. Discuss the possibilities with us.
Thank you!
We will get back to you within 5 days, please check your spam folder
Back to Idoven
Oops! Something went wrong while submitting the form.
Thank you!
We will get back to you within 5 days, please check your spam folder
Back to Idoven
Oops! Something went wrong while submitting the form.